- Home
- TTNP vs SSY Comparison
TTNP vs SSY Comparison
Compare TTNP & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- SSY
- Stock Information
- Founded
- TTNP 1991
- SSY 1959
- Country
- TTNP United States
- SSY United States
- Employees
- TTNP 4
- SSY N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- SSY Hospital/Nursing Management
- Sector
- TTNP Health Care
- SSY Health Care
- Exchange
- TTNP Nasdaq
- SSY Nasdaq
- Market Cap
- TTNP 5.9M
- SSY 6.2M
- IPO Year
- TTNP 1996
- SSY N/A
- Fundamental
- Price
- TTNP $4.40
- SSY $0.88
- Analyst Decision
- TTNP
- SSY
- Analyst Count
- TTNP 0
- SSY 0
- Target Price
- TTNP N/A
- SSY N/A
- AVG Volume (30 Days)
- TTNP 44.6K
- SSY 192.4K
- Earning Date
- TTNP 08-14-2025
- SSY 05-13-2025
- Dividend Yield
- TTNP N/A
- SSY N/A
- EPS Growth
- TTNP N/A
- SSY N/A
- EPS
- TTNP N/A
- SSY 0.25
- Revenue
- TTNP N/A
- SSY $31,094,000.00
- Revenue This Year
- TTNP N/A
- SSY N/A
- Revenue Next Year
- TTNP N/A
- SSY N/A
- P/E Ratio
- TTNP N/A
- SSY $3.57
- Revenue Growth
- TTNP N/A
- SSY N/A
- 52 Week Low
- TTNP $3.03
- SSY $0.62
- 52 Week High
- TTNP $14.80
- SSY $1.91
- Technical
- Relative Strength Index (RSI)
- TTNP 48.35
- SSY 41.55
- Support Level
- TTNP $4.23
- SSY $0.95
- Resistance Level
- TTNP $4.65
- SSY $1.06
- Average True Range (ATR)
- TTNP 0.27
- SSY 0.09
- MACD
- TTNP -0.03
- SSY -0.01
- Stochastic Oscillator
- TTNP 30.67
- SSY 11.21
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.